WADA, in consultation with signatories and governments, shall establish a monitoring program regarding substances which are not on the Prohibited List, but which WADA wishes to monitor in order to detect patterns of misuse in sport.
WADA shall publish, in advance of any testing, the substances that will be monitored. Laboratories will report the instances of reported use or detected presence of these substances to WADA periodically on an aggregate basis by sport and whether the samples were collected in-competition or out–of-competition. Such reports shall not contain additional information regarding specific samples.
WADA shall make available to International Federations and National Anti-Doping Organizations, on at least an annual basis, aggregate statistical information by sport regarding the additional substances. WADA shall implement measures to ensure that strict anonymity of individual Athletes is maintained with respect to such reports. The reported use or detected presence of a monitored substance shall not constitute an anti-doping rule violation.